44 related articles for article (PubMed ID: 22526364)
1. The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma.
Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS
Ann Hematol; 2012 Sep; 91(9):1383-91. PubMed ID: 22526364
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma.
Saglam B; Albayrak M; Yıldız A; Tığlıoğlu P; Tığlıoğlu M; Aras MR; Yilmaz F; Maral S; A Öztürk HB
Niger J Clin Pract; 2023 Oct; 26(10):1512-1518. PubMed ID: 37929528
[TBL] [Abstract][Full Text] [Related]
3. Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma.
Smith A; Crouch S; Howell D; Burton C; Patmore R; Roman E
Cancer Epidemiol; 2015 Dec; 39(6):1103-12. PubMed ID: 26341588
[TBL] [Abstract][Full Text] [Related]
4. Impact of comorbidities on outcomes of elderly patients with diffuse large B-cell lymphoma.
Saygin C; Jia X; Hill B; Dean R; Pohlman B; Smith MR; Jagadeesh D
Am J Hematol; 2017 Oct; 92(10):989-996. PubMed ID: 28612386
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence.
de Pádua Covas Lage LA; De Vita RN; de Oliveira Alves LB; Jacomassi MD; Culler HF; Reichert CO; de Freitas FA; Rocha V; Siqueira SAC; de Oliveira Costa R; Pereira J
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672542
[TBL] [Abstract][Full Text] [Related]
6. Association between serum albumin levels and survival in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective study.
Hu X; Feng X; Wang H; Miao Y; Lian X; Gao Q; Gao Y; Zhai X; Zhang D; Niu B; Wang Y
Transl Cancer Res; 2023 Jun; 12(6):1577-1587. PubMed ID: 37434675
[TBL] [Abstract][Full Text] [Related]
7. Delirium is significantly associated with hospital frailty risk score derived from administrative data.
Lim Z; Ling N; Ho VWT; Vidhya N; Chen MZ; Wong BLL; Ng SE; Murphy D; Merchant RA
Int J Geriatr Psychiatry; 2023 Jan; 38(1):e5872. PubMed ID: 36683168
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma.
Miller SD; Lozano-Ortega G; Mutebi A; Briggs O; Sail K; Elliott B; Kalsekar A
J Comp Eff Res; 2023 Jan; 12(1):e220146. PubMed ID: 36417238
[No Abstract] [Full Text] [Related]
9. Outcomes of Care by Geriatricians and Non-geriatricians in an Academic Hospital.
Merchant RA; Ho VWT; Chen MZ; Wong BLL; Lim Z; Chan YH; Ling N; Ng SE; Santosa A; Murphy D; Vathsala A
Front Med (Lausanne); 2022; 9():908100. PubMed ID: 35733862
[TBL] [Abstract][Full Text] [Related]
10. Low Geriatric Nutritional Risk Index Is Associated with Poorer Prognosis in Elderly Diffuse Large B-Cell Lymphoma Patients Unfit for Intensive Anthracycline-Containing Therapy: A Real-World Study.
Chuang TM; Liu YC; Hsiao HH; Wang HC; Du JS; Yeh TJ; Gau YC; Ke YL; Yang CI; Lee CP; Hsu CM; Cho SF
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579119
[TBL] [Abstract][Full Text] [Related]
11. Rehabilitation in patients with lymphoma: An overview of Systematic Reviews.
Amatya B; Khan F; Lew TE; Dickinson M
J Rehabil Med; 2021 Mar; 53(3):jrm00163. PubMed ID: 33710351
[TBL] [Abstract][Full Text] [Related]
12. Determinants of adherence to physical cancer rehabilitation guidelines among cancer patients and cancer centers: a cross-sectional observational study.
IJsbrandy C; Ottevanger PB; Gerritsen WR; van Harten WH; Hermens RPMG
J Cancer Surviv; 2021 Feb; 15(1):163-177. PubMed ID: 32986232
[TBL] [Abstract][Full Text] [Related]
13. Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
Kang HJ; Lee HH; Jung SE; Park KS; O JH; Jeon YW; Choi BO; Cho SG
PLoS One; 2020; 15(9):e0238807. PubMed ID: 32960887
[TBL] [Abstract][Full Text] [Related]
14. Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review.
Zhu J; Yang Y; Tao J; Wang SL; Chen B; Dai JR; Hu C; Qi SN; Li YX
Leukemia; 2020 Oct; 34(10):2576-2591. PubMed ID: 32651542
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent.
Kocher F; Mian M; Seeber A; Fiegl M; Stauder R
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32252438
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience.
Cuellar LE; Anampa-Guzmán A; Holguín AM; Velarde J; Portillo-Alvarez D; Zuñiga-Ninaquispe MA; Luna-Reyes ER; Vásquez J; Jeter JM; Winkfield KM
Infect Agent Cancer; 2018; 13():27. PubMed ID: 30083224
[TBL] [Abstract][Full Text] [Related]
17. A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one.
Go SI; Park MJ; Song HN; Kim HG; Kang MH; Kang JH; Kim HR; Lee GW
Oncotarget; 2017 Jul; 8(29):47007-47019. PubMed ID: 28388585
[TBL] [Abstract][Full Text] [Related]
18. Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma.
Cho SF; Liu YC; Hsiao HH; Huang CT; Tsai YF; Wang HC; Lin SF; Liu TC
Sci Rep; 2017 Mar; 7():44282. PubMed ID: 28290477
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma.
Zhao H; Wang T; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Yan B; Wu X; Da W; Zhang Y
Onco Targets Ther; 2016; 9():1795-9. PubMed ID: 27069369
[TBL] [Abstract][Full Text] [Related]
20. Variation in guideline adherence in non-Hodgkin's lymphoma care: impact of patient and hospital characteristics.
Stienen JJ; Hermens RP; Wennekes L; van de Schans SA; van der Maazen RW; Dekker HM; Liefers J; van Krieken JH; Blijlevens NM; Ottevanger PB;
BMC Cancer; 2015 Aug; 15():578. PubMed ID: 26253203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
